Bax/Bcl-2 Ratio as a predictive marker for therapeutic response, after thymectomy in patients with myasthenia gravis

被引：0
|
作者：
Salakou, S [1 ]
Tsamandas, A [1 ]
Tsibri, E [1 ]
Apostolakis, E [1 ]
Bonikos, D [1 ]
Papapetropoulos, Y [1 ]
Dougenis, D [1 ]
机构：
[1] Univ Patras, Sch Med, GR-26110 Patras, Greece
来源：
JOURNAL OF NEUROLOGY | 2005年 / 252卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [1] Bax/Bcl-2 ratio as a predictive marker for therapeutic response, after thymectomy in patients with myasthenia gravis
    Salakou, S
    Tsamandas, AC
    Tsibri, E
    Apostolakis, D
    Bonikos, D
    Papapetropoulos, T
    Dougenis, D
    [J]. MODERN PATHOLOGY, 2005, 18 : 294A - 294A
  • [2] Bax/bcl-2 ratio as a predictive marker for therapeutic response, after thymectomy in patients with myasthenia gravis
    Salakou, S.
    Tsamandas, A.
    Tsibri, E.
    Apostolakis, E.
    Bonikos, D.
    Papapetropoulos, T.
    Dougenis, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 157 - 157
  • [3] Bax/Bcl-2 ratio as a predictive marker for therapeutic response, after thymectomy in patients with myasthenia gravis
    Salakou, S
    Tsamandas, AC
    Tsibri, E
    Apostolakis, E
    Bonikos, D
    Papapetropoulos, T
    Dougenis, D
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 294A - 294A
  • [4] bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer
    Mackey, TJ
    Borkowski, A
    Amin, P
    Jacobs, SC
    Kyprianou, N
    [J]. UROLOGY, 1998, 52 (06) : 1085 - 1090
  • [5] The potential role of bcl-2, bax, bax/bcl-2 ratio and ki67 expression in patients with myasthenia gravis
    Salakou, S.
    Tsamandas, A.
    Tsibri, E.
    Apostolakis, E.
    Bonikos, D.
    Papapetropoulos, T.
    Dougenis, D.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 106 - 106
  • [6] Bcl-2-/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer
    Scopa, CD
    Vagianos, C
    Kardamakis, D
    Kourelis, TG
    Kalofonos, HP
    Tsamandas, AC
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2001, 9 (04) : 329 - 334
  • [7] Bcl-2/bax ratio as a potential marker of therapeutic response to radiation in prostate cancer patients.
    Mackey, TJ
    Borkowski, A
    Jacobs, SC
    Kyprianou, N
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05): : 178 - 178
  • [8] Increased Bax/Bcl-2 ratio upregulates caspase-3 and increases apoptosis in thymus of patients with myasthenia gravis
    Salakou, S
    Tsamandas, AC
    Tsibri, E
    Dougenis, D
    Bonikos, D
    Papapetropoulos, T
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 175 - 175
  • [9] THERAPEUTIC RESPONSE INTERVAL AFTER THYMECTOMY FOR THYMOMA IN MYASTHENIA-GRAVIS
    VICENS, C
    PONSETI, JM
    CANO, ML
    FORT, JM
    SAINZ, B
    ARMENGOL, M
    [J]. BRITISH JOURNAL OF SURGERY, 1995, 82 : 41 - 41
  • [10] Bax/bcl-2 ratio as a predictive marker for liver fibrosis and failure. An experimental study
    Tsamandas, A
    Kalogeropoulou, C
    Ravazoula, P
    Tepetes, K
    Petsas, T
    Karavias, D
    Bonikos, D
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 295A - 296A
12345